EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy

James Blackmur iD, Scottish Malignant Ureteric Obstruction Study Group

British Journal of Surgery · 31.01.2024 · 111 (2)

DOI: 10.1093/bjs/znae035 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Surgery, online erschienen am 26.02.2024. Verfasst von James Blackmur und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Edinburgh, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK. Hauptthemen laut MEDLINE: Nephrostomy, Percutaneous, Ureteral Obstruction, Ureter. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chief Scientist Office, SCREDS Clinical Lectureship, University of Edinburgh.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lay summary Malignant ureteric obstruction (MUO) is frequently encountered in patients with advanced cancers. In the largest study to date, assessing 852 patients from across Scotland, the authors demonstrated the presence of MUO as a marker of advanced disease across cancer types, with poor survival for many patients, even with intervention. There is uncertainty in optimal management of this condition, with marked differences in management between hospitals. Treatment to relieve the obstruction does not guarantee either improvement in kidney function or progression to further oncological treatment. The authors have developed a prognostic tool to estimate outcomes after intervention for MUO, and advocate its use for clinicians along with other data presented for patient counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrostomy, PercutaneousUreteral ObstructionUreterHumansStentsRetrospective Studies

Autor:innen und Institutionen

  • Department of Urology, University of Edinburgh, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK.

ORCID-Profile: James Blackmur

Förderung

  • Chief Scientist Office
  • SCREDS Clinical Lectureship
  • University of Edinburgh
  • British Society of Interventional Radiology Audit Bursary
  • Royal College of Radiologists
  • NRS Career Researcher Fellowship

Zitieren

APA

Blackmur, J., & Scottish Malignant Ureteric Obstruction Study Group (2024). Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy. British Journal of Surgery, 111(2). https://doi.org/10.1093/bjs/znae035

Vancouver

Blackmur J, Scottish Malignant Ureteric Obstruction Study Group. Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy. British Journal of Surgery. 2024;111(2). doi:10.1093/bjs/znae035

BibTeX
@article{Blackmur2024,
  author = {Blackmur, James and Scottish Malignant Ureteric Obstruction Study Group, Scottish Malignant Ureteric Obstruction Study Group},
  title = {Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy},
  journal = {British Journal of Surgery},
  year = {2024},
  volume = {111},
  number = {2},
  doi = {10.1093/bjs/znae035}
}
Kostenlos starten →